IO Biotech(IOBT) - 2025 Q2 - Quarterly Results

(OBIOTECH Breaking Boundaries. Igniting Change. (O Agenda for Today's Call | Topic | Speaker | | --- | --- | | Introduction | Mai-Britt Zocca, Ph.D., chief executive officer | | Cylembio Phase 3 Data | Qasim Ahmad, M.D., chief medical officer | | First-line Advanced Melanoma Treatment Landscape | Omid Hamid, MD, Director, Clinical Research and | | | Immunotherapy at The Angeles Clinic and Research | | | Institute, A Cedars Sinai Affiliate | | Company Milestones | Amy Sullivan, chief financial officer | (0 I ...